US Stock Futures Signal Higher Start On Wall Street

Loading...
Loading...
Pre-open movers
US stock futures traded higher in early pre-market trade. Futures for the Dow Jones Industrial Average surged 33 points to 16,687.00, while the Standard & Poor's 500 index futures rose 4.10 points to 1,913.30. Futures for the Nasdaq 100 index gained 7.75 points to 3,729.00.
A Peek Into Global Markets
European markets were mostly higher today, with the Spanish Ibex Index rising 0.29%, STOXX Europe 600 Index falling 0.04%. German DAX 30 index surged 0.15%, French CAC 40 Index rose 0.06% and London's FTSE 100 Index gained 0.06%. French producer prices declined 0.1% in April versus March, while consumer spending slipped 0.3% in April versus a 0.6% growth in March. In Asian markets, Japan's Nikkei Stock Average jumped 0.24%, Hong Kong's Hang Seng Index rose 0.59%, China's Shanghai Composite Index surged 0.77% and India's BSE Sensex rose 0.03%.
Broker Recommendation
Analysts at Deutsche Bank downgraded Dollar General
DG
from “buy” to “hold.” The target price for Dollar General has been lowered from $65 to $60. Dollar General's shares closed at $56.30 yesterday.
Breaking news
  • PetroLogistics LP PDH announced today that it and its general partner, PetroLogistics GP LLC, have entered into a definitive agreement to be acquired by Flint Hills Resources, LLC, a subsidiary of Koch Industries. To read the full news, click here.
  • Trimel Pharmaceuticals TRLPF announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD). FOD, also known as anorgasmia, is characterized by a delay, absence or reduced intensity of orgasm, causing clinically significant distress. To read the full news, click here.
  • Toll Brothers TOL reported a rise in its fiscal second-quarter profit. Toll Brothers posted its quarterly profit of $65.2 million, or $0.35 per share, versus a year-ago profit of $24.7 million, or $0.14 per share. To read the full news, click here.
  • Valeant Pharmaceuticals International VRX today announced that it has submitted an increase to its April 22 proposal to merge with Allergan AGN to Allergan's Board of Directors. To read the full news, click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsDeutsche BankUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...